Indrayani Biotech Ltd has informed BSE that the meeting of the Board of Directors inter alia, to consider and approve unaudited financial results (standalone and consolidated) for quarter and Half year ended 30th September 2025 has been postponed.
Indrayani Biotech Ltd has informed BSE that the meeting of the Board of Directors inter alia, to consider and approve unaudited financial results (standalone and consolidated) for quarter and Half year ended 30th September 2025 has been postponed.